Literature DB >> 24034480

Brief literature review for the WHO global influenza research agenda--highly pathogenic avian influenza H5N1 risk in humans.

Maria D Van Kerkhove1.   

Abstract

Highly pathogenic avian influenza A H5N1 viruses remain a significant health threat to humans given the continued rare occurrence of human cases with a high case fatality rate. This brief literature review summarizes available evidence of risk factors for H5N1 infection in humans and updates a recent systematic review published in early 2011. Several epidemiologic studies have been published to evaluate the risk factors for H5N1 infection in humans, including contact with poultry and poultry products and non-poultry-related contact such as from H5N1-contaminated water. While most H5N1 cases are attributed to exposure to sick poultry, it is unclear how many may be due to human-to-human transmission. The collective results of published literature suggest that transmission risk of H5N1 from poultry to humans may be highest among individuals who may have been in contact with the highest potential concentrations of virus shed by poultry. This suggests that there may be a threshold of virus concentration needed for effective transmission and that circulating H5N1 strains have not yet mutated to transmit readily from either poultry to human or from human to human. However, the mode of potential transmission can be quite varied throughout different countries and by study with exposures ranging from visiting a wet market, preparing infected poultry for consumption, to swimming or bathing in ponds frequented by poultry. Several important data gaps remain in the understanding of the epidemiology of H5N1 in humans and limit our ability to interpret the results of the available H5N1 seroepidemiologic studies.
© 2013 Blackwell Publishing Ltd.

Entities:  

Keywords:  H5N1; exposure; highly pathogenic avian influenza; human-animal interface; risk factors; seroprevalence

Mesh:

Year:  2013        PMID: 24034480     DOI: 10.1111/irv.12077

Source DB:  PubMed          Journal:  Influenza Other Respir Viruses        ISSN: 1750-2640            Impact factor:   4.380


  23 in total

1.  A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades.

Authors:  Wakako Furuyama; Pierce Reynolds; Elaine Haddock; Kimberly Meade-White; Mai Quynh Le; Yoshihiro Kawaoka; Heinz Feldmann; Andrea Marzi
Journal:  NPJ Vaccines       Date:  2020-01-10       Impact factor: 7.344

2.  Survival of Highly Pathogenic Avian Influenza H5N1 Virus in Tissues Derived from Experimentally Infected Chickens.

Authors:  Yu Yamamoto; Kikuyasu Nakamura; Masaji Mase
Journal:  Appl Environ Microbiol       Date:  2017-08-01       Impact factor: 4.792

Review 3.  H5 influenza, a global update.

Authors:  Rhodri Harfoot; Richard J Webby
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 3.422

4.  A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets.

Authors:  Feng Liu; Xiangjie Sun; Jeffery Fairman; David B Lewis; Jacqueline M Katz; Min Levine; Terrence M Tumpey; Xiuhua Lu
Journal:  Virology       Date:  2016-03-21       Impact factor: 3.616

5.  Avian influenza A(H5N1) and A(H9N2) seroprevalence and risk factors for infection among Egyptians: a prospective, controlled seroepidemiological study.

Authors:  Mokhtar R Gomaa; Ahmed S Kayed; Mona A Elabd; Dina Abu Zeid; Shaimaa A Zaki; Amira S El Rifay; Lobna S Sherif; Pamela P McKenzie; Robert G Webster; Richard J Webby; Mohamed A Ali; Ghazi Kayali
Journal:  J Infect Dis       Date:  2014-10-29       Impact factor: 5.226

6.  Avian influenza virus directly infects human natural killer cells and inhibits cell activity.

Authors:  Huawei Mao; Yinping Liu; Sin Fun Sia; J S Malik Peiris; Yu-Lung Lau; Wenwei Tu
Journal:  Virol Sin       Date:  2017-02-23       Impact factor: 4.327

Review 7.  Recent Advances in Plasma-Engineered Polymers for Biomarker-Based Viral Detection and Highly Multiplexed Analysis.

Authors:  Seyyed Mojtaba Mousavi; Seyyed Alireza Hashemi; Masoomeh Yari Kalashgrani; Ahmad Gholami; Navid Omidifar; Aziz Babapoor; Neralla Vijayakameswara Rao; Wei-Hung Chiang
Journal:  Biosensors (Basel)       Date:  2022-04-28

8.  Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor.

Authors:  Min-Suk Song; Gyanendra Kumar; William R Shadrick; Wei Zhou; Trushar Jeevan; Zhenmei Li; P Jake Slavish; Thomas P Fabrizio; Sun-Woo Yoon; Thomas R Webb; Richard J Webby; Stephen W White
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

9.  A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In Vitro.

Authors:  Jeremy C Jones; Bindumadhav M Marathe; Christian Lerner; Lukas Kreis; Rodolfo Gasser; Philippe Noriel Q Pascua; Isabel Najera; Elena A Govorkova
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

10.  Emergence of infectious malignant thrombocytopenia in Japanese macaques (Macaca fuscata) by SRV-4 after transmission to a novel host.

Authors:  Munehiro Okamoto; Takayuki Miyazawa; Shigeru Morikawa; Fumiko Ono; Shota Nakamura; Eiji Sato; Tomoyuki Yoshida; Rokusuke Yoshikawa; Kouji Sakai; Tetsuya Mizutani; Noriyo Nagata; Jun-ichiro Takano; Sachi Okabayashi; Masataka Hamano; Koji Fujimoto; Takaaki Nakaya; Tetsuya Iida; Toshihiro Horii; Takako Miyabe-Nishiwaki; Akino Watanabe; Akihisa Kaneko; Akatsuki Saito; Atsushi Matsui; Toshiyuki Hayakawa; Juri Suzuki; Hirofumi Akari; Tetsuro Matsuzawa; Hirohisa Hirai
Journal:  Sci Rep       Date:  2015-03-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.